Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Soft white paraffin (also known as white soft paraffin or white petrolatum) is a semi-solid mixture of hydrocarbons widely used as an emollient, skin protectant, and ointment base. It functions primarily by forming an occlusive barrier on the skin surface, which prevents transepidermal water loss, thereby hydrating the stratum corneum and facilitating skin barrier recovery. In clinical research, it is frequently employed as an inert vehicle or placebo control in trials evaluating topical dermatological treatments. For example, in a pilot feasibility randomized controlled trial conducted by James Cook University in Australia, soft white paraffin was utilized as a comparator arm against active antimicrobial ointments (mupirocin and hydrogen peroxide) for the treatment of mild impetigo to support antimicrobial stewardship goals.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on soft white paraffin.